Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4563398
Max Phase: Preclinical
Molecular Formula: C55H87N3O13
Molecular Weight: 998.31
Molecule Type: Unknown
Associated Items:
ID: ALA4563398
Max Phase: Preclinical
Molecular Formula: C55H87N3O13
Molecular Weight: 998.31
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)C(N3CCN(CCO)C3=O)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)CC[C@H]1O
Standard InChI: InChI=1S/C55H87N3O13/c1-34-15-11-10-12-16-36(3)44(58-26-25-56(27-28-59)54(58)66)33-42-21-19-40(7)55(67,71-42)51(63)52(64)57-24-14-13-17-43(57)53(65)70-46(37(4)31-41-20-22-45(60)47(32-41)68-8)23-18-35(2)30-39(6)49(62)50(69-9)48(61)38(5)29-34/h10-12,15-16,30,34-35,37-38,40-47,49-50,59-60,62,67H,13-14,17-29,31-33H2,1-9H3/b12-10+,15-11+,36-16+,39-30+/t34-,35+,37-,38-,40-,41+,42+,43+,44?,45-,46+,47-,49-,50+,55-/m1/s1
Standard InChI Key: HZGNNLZIIASQPE-QVKDGJRMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 998.31 | Molecular Weight (Monoisotopic): 997.6239 | AlogP: 6.09 | #Rotatable Bonds: 8 |
Polar Surface Area: 212.91 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.96 | CX Basic pKa: | CX LogP: 6.76 | CX LogD: 6.76 |
Aromatic Rings: 0 | Heavy Atoms: 71 | QED Weighted: 0.12 | Np Likeness Score: 1.55 |
1. Abdel-Magid AF.. (2019) Rapalogs Potential as Practical Alternatives to Rapamycin., 10 (6): [PMID:31223435] [10.1021/acsmedchemlett.9b00215] |
Source(1):